JOHNSON & JOHNSON

Pharmaceutical Preparations·NEW BRUNSWICK, NJ·FY end 01/03·CIK 200406

Board of Directors

12 members · 11 independent · FY 2025

Director	Role	Tenure	Age	Committees	Indep.	Annual fees
Mary C. Beckerle, Ph.D.	Director	10y	71	TechRegulatory Compliance & Sustainability		—
Jennifer A. Doudna, Ph.D.	Director	7y	62	NCGTech		—
Joaquin Duato	CEO and Director	3y	63	Finance	—	—
Marillyn A. Hewson	Lead Independent Director	6y	72	NCGCompFinance		$413,000
Paula A. Johnson, M.D.	Director	2y	66	NCGTech		—
Hubert Joly	Director	6y	66	AuditNCG		$367,548
Mark B. McClellan, M.D., Ph.D.	Director	12y	62	Regulatory Compliance & SustainabilityTech		—
John G. Morikis	Director	1y	62	AuditComp		—
Daniel E. Pinto	Director	1y	63	AuditComp		—
Mark A. Weinberger	Director	6y	64	Regulatory Compliance & SustainabilityAudit		$355,000
Nadja Y. West, M.D.	Director	5y	64	Regulatory Compliance & SustainabilityTech		—
Eugene A. Woods	Director	2y	61	CompRegulatory Compliance & Sustainability		$347,158

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.